Adverse reactions to antinauseants in common use in the UK.
Soukop
M
M
Glasgow Royal Infirmary University NHS Trust.
D000818:Animals; D000932:Antiemetics / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects; D002186:Cannabinoids / Q000009:adverse effects; D018680:Cholinergic Antagonists / Q000009:adverse effects; D002986:Clinical Trials as Topic; D065127:Dopamine D2 Receptor Antagonists; D006321:Heart / Q000187:drug effects; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D064729:Neurokinin-1 Receptor Antagonists; D018570:Risk Assessment; D012702:Serotonin Antagonists / Q000009:adverse effects*; D013256:Steroids / Q000009:adverse effects; D006113:United Kingdom
D000932:Antiemetics; D000970:Antineoplastic Agents; D002186:Cannabinoids; D018680:Cholinergic Antagonists; D065127:Dopamine D2 Receptor Antagonists; D064729:Neurokinin-1 Receptor Antagonists; D012702:Serotonin Antagonists; D013256:Steroids; D001569:Benzodiazepines